Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. - Wikidata - awgldk - TriplyDB

Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients.

Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients.

http://www.wikidata.org/entity/Q53516105

about

Vitamin D and its effects on cardiovascular diseases: a comprehensive review Risk factors of one year increment of coronary calcifications and survival in hemodialysis patients Asymmetric dimethylarginine: a novel cardiovascular risk factor in end-stage renal disease.Calcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients.Chronic kidney disease-related atherosclerosis - proteomic studies of blood plasma.Effect of changes in the intravascular volume during hemodialysis on blood viscoelasticity Assessment of potential biomarkers of subclinical vitamin K deficiency in patients with end-stage kidney disease.Lysophosphatidylcholine, oxidized low-density lipoprotein and cardiovascular disease in Korean hemodialysis patients: analysis at 5 years of follow-up Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus.Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients.Associations between oxidized LDL to LDL ratio, HDL and vascular calcification in the feet of hemodialysis patients.Low bone volume--a risk factor for coronary calcifications in hemodialysis patients Risk of Retinal Artery Occlusion in Patients With End-Stage Renal Disease: A Retrospective Large-Scale Cohort Study.Right coronary artery becomes stiffer with increase in elastin and collagen in right ventricular hypertrophy.Stem cell aging: survival of the laziest?The role of the intraplaque vitamin d system in atherogenesis.Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals.Coronary stent thrombosis in patients with chronic renal insufficiency.Use of drug-eluting stents in patients with coronary artery disease and renal insufficiency.Cinacalcet: a pharmacoeconomic review of its use in secondary hyperparathyroidism in end-stage renal disease.Vitamin D and serum leptin: a systematic review and meta-analysis of observational studies and randomized controlled trials.Roles of platelet-derived growth factor in vascular calcification.Clinical analysis of pulmonary infection in hemodialysis patients.Advanced Oxidation Protein Products and Carbonylated Proteins as Biomarkers of Oxidative Stress in Selected Atherosclerosis-Mediated Diseases.Cardiovascular disease complications in systemic lupus erythematosus.Wishful Thinking: The Surprisingly Sparse Evidence for a Relationship between Oxidative Stress and Cardiovascular Disease in Hemodialysis Patients.Combined application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in early diagnosis of vulnerable carotid atherosclerotic plaques.Low serum fetuin A levels and incident stroke in patients with maintenance haemodialysis.Switching from calcium carbonate to sevelamer hydrochloride has suppressive effects on the progression of aortic calcification in hemodialysis patients: assessment using plain chest X-ray films.Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden?Risk factors for heart valve calcification in chronic kidney disease.Waist circumference is associated with carotid intima media thickness in peritoneal dialysis patients.Effect of sevelamer hydrochloride exposure on carotid intima media thickness in hemodialysis patients

P2860

Q28066198-BDFAF0A6-6A5A-4030-9B63-67320ECC31D5 Q33611410-6A125F37-139C-491E-A6B5-141C6258276C Q34201581-3DC7B4B8-30FD-4B8C-9868-9C09916FAD98 Q34547461-DA344429-A63E-4680-8C75-74BCC53E7F5A Q35038375-58A4D5ED-00AC-4DC1-965B-1884F40F0B40 Q35093887-E632B4A6-DD09-4810-9471-E7D3BE57E7E8 Q35147833-3AF732F9-C8B9-4732-A246-2645C9AB8D8D Q36589502-121584E7-C690-4C88-A612-E410F6274E6C Q36952629-BF34FA47-CD0A-46C0-BD9B-718A9128C514 Q37075732-5A49BA1B-5C2A-4051-A284-AE2C8328B8BC Q37078140-195D7AAB-1948-4E49-9AD9-C30EEAA75042 Q37087934-E877619C-D322-4145-9ED2-150D6057D928 Q37206787-4FC5F540-4024-46C7-90BD-089CE18D5E0A Q37233123-549D4373-ED2B-447A-8B7E-1580EA1045D3 Q37344581-55004234-6DEB-4282-9DD3-973581388808 Q37466074-0E09D9AB-0DB9-482F-AF01-E69C18E1B171 Q37492503-43C201D9-1AF2-42A5-9C71-972544E4011D Q37582058-127DC38C-D609-4B0E-8011-2B095C732909 Q37684624-F04C7943-403C-4602-8A8F-B1235998BBAB Q37916534-560D3591-BB09-4C02-8F65-C56B49854A28 Q39038137-22068883-2408-4632-ABB9-364C70E361C2 Q39280581-7E732973-C644-47F3-8C3B-4B4C8B3CD7E2 Q40240848-425486D6-42D8-40AE-9FE3-53DC80B86811 Q41528545-132B6673-30A1-4DC3-B0C3-92D504A90C15 Q43061600-81F94D62-3A32-465A-898F-EA996704270F Q44916889-98AB0C78-247B-4EFF-9175-B9A6BACC0E32 Q45407413-D8B3C4FB-B980-4389-933E-FD8FEAC9DBF0 Q46138663-96B45E22-2062-4E4C-A555-99193DF89B3B Q46240729-D9A1F7D9-7097-4CA9-AF2A-56E32CD88311 Q47732797-75867387-1E82-465A-B091-EA33C39B9938 Q49557576-8F5AA9BF-DF3A-4A87-9538-D75F0CE0F88F Q51342289-AA2C41A4-AE03-47ED-A0C0-6ED4E353F7C8 Q57220223-6F78B677-466A-4BA5-B5B4-7BA2C4DBA9A7

P2860

Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients.

http://www.wikidata.org/entity/Q53516105

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Factors involved in vascular c ...... enance haemodialysis patients.

@en

Factors involved in vascular c ...... enance haemodialysis patients.

@nl

type

label

Factors involved in vascular c ...... enance haemodialysis patients.

@en

Factors involved in vascular c ...... enance haemodialysis patients.

@nl

prefLabel

Factors involved in vascular c ...... enance haemodialysis patients.

@en

Factors involved in vascular c ...... enance haemodialysis patients.

@nl

P1433

Q53516105-0EEA835D-8A87-427C-983A-53E06EE374F2

P1476

Q53516105-5FDA68AE-581D-40B4-A4EB-251F8212095F

P2093

Q53516105-0DE1E662-2BB3-44E8-847C-C03CFDD25D44

Q53516105-24167707-96CB-4101-87F5-4FAE8659EECC

Q53516105-3B2C4A5E-AD56-4899-9DF1-4ACFD7E8791D

Q53516105-4EDDFF52-3EF3-433C-ABF7-BE8C00187550

Q53516105-56B909DC-EE7B-4FB8-97C6-8A265F6D71F1

Q53516105-5F8A8F35-8CC4-41A0-AF52-3371FCAE094C

Q53516105-6754F416-6508-44B1-AB6B-B81A27954DE2

Q53516105-68576043-1FD4-41C2-937A-1A96F32B2B65

Q53516105-7050804C-7529-40E7-AEE3-7219524AE6A6

Q53516105-706DC1C7-56E9-4ACA-B412-16D0D168B813

P304

Q53516105-EE9EBEB5-7047-47F6-A708-3F3F6C239E19

P31

Q53516105-FD01EAA8-DE0D-4AD9-A989-9104BFA4B397

P356

Q53516105-A5D0D802-5015-4A2A-BDFC-9160F808147D

P407

Q53516105-4659183B-EB33-4D6E-930E-465A32E962C0

P433

Q53516105-E935B4F4-D972-413C-B7B0-CCE4E6941708

P478

Q53516105-1309B814-3F4C-4DFB-A2AF-C11EAD8D1C8A

P50

Q53516105-0B0D7CC8-5181-4EFD-B3A1-5A040C756BAD

Q53516105-B1E46974-443A-42EF-8E11-7C3AD1A00762

P577

Q53516105-F36526B3-A7ED-4BA0-90A6-54297912CA0F

P5875

Q53516105-577926F4-FDC0-41CC-B8B8-7569F8E40AA4

P698

Q53516105-7ECFAE85-134B-480A-A3AF-B81364742118

P921

Q53516105-3175D61D-CEBA-4F44-8887-0194E8B7472B

P356

P1433

Nephrology Dialysis Transplantation

P1476

Factors involved in vascular c ...... enance haemodialysis patients.

@en

P2093

Andrzej Kraśniak

http://www.w3.org/2001/XMLSchema#string

Dorota Szumilak

http://www.w3.org/2001/XMLSchema#string

Ewa Wicher-Muniak

http://www.w3.org/2001/XMLSchema#string

Grzegorz Chmiel

http://www.w3.org/2001/XMLSchema#string

Jean-Claude Souberbielle

http://www.w3.org/2001/XMLSchema#string

Maciej Drozdz

http://www.w3.org/2001/XMLSchema#string

Martyna Michałek

http://www.w3.org/2001/XMLSchema#string

Małgorzata Konieczyńska

http://www.w3.org/2001/XMLSchema#string

Mieczysław Pasowicz

http://www.w3.org/2001/XMLSchema#string

Piotr Klimeczek

http://www.w3.org/2001/XMLSchema#string

P304

515-521

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFL564

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Tilman B Drueke

P577

2006-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6744442

http://www.w3.org/2001/XMLSchema#string

P698

17050638

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis